As a mutual and regional bank, Crédit Agricole Alpes Provence mobilizes its financial and human resources to support the economic development of its territory, particularly within the framework of its partnership with Eurobiomed, supporting health innovators. Today, we focus on the CAAP INNOV’ECO endowment fund.
Because innovation and entrepreneurship are its driving forces, the Capital & Innovation division of Crédit Agricole Alpes Provence, with its CAAP INNOV’ECO Endowment Fund and its CAAP CREATION innovation capital fund, works daily to facilitate, finance, and highlight the creation and development of innovative companies in Marseille, Aix-en-Provence, Avignon, Gap, etc.
Approximately fifteen projects annually
Crédit Agricole Alpes Provence distinguishes itself through its commitment to local innovation and entrepreneurship via CAAP INNOV’ECO. Since its inception in 2015, this fund has been endowed annually with 1% of the bank's net profit to support innovative projects and accompanying structures in Bouches-du-Rhône, Vaucluse, and Hautes-Alpes, offering, among other things, a valuable honor loan to founders of high-tech startups. Each year, approximately fifteen projects are supported in this manner, following a rigorous selection process.
Providing a significant impetus, the financing offered by CAAP INNOV’ECO serves as a catalyst for the launch and growth of innovative companies. Without collateral requirements, this loan, amounting up to €30,000 over 60 months (with a 12-month deferral) at a 0% interest rate, enables entrepreneurs to initiate their projects under optimal conditions.
Eligibility Criteria: To benefit from this financial support, applicants must be accompanied by an Endowment Fund partner, such as Eurobiomed, and be a young startup presenting a disruptive innovation with a significant impact on the Regional Bank's territory.
Project leaders must establish their company and possess a KBIS registration, then present their project to the Endowment Fund's Board of Directors to secure its approval.
More information is available on the Capital & Innovation division's website
